Prognostic Model of Rituximab in the Treatment of MN
NCT05667909
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Membranous Nephropathy
Interventions
DRUG:
Rituximab
Sponsor
Qianfoshan Hospital